Ignite Creation Date:
2025-12-24 @ 6:48 PM
Ignite Modification Date:
2026-02-21 @ 6:45 PM
Study NCT ID:
NCT00851357
Status:
COMPLETED
Last Update Posted:
2020-02-13
First Post:
2009-02-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Telephone Counseling and the Distribution of Nicotine Patches to Smokers
Sponsor:
Organization:
Raw JSON
{'hasResults': True, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D016540', 'term': 'Smoking Cessation'}, {'id': 'D020340', 'term': 'Tobacco Use Cessation'}, {'id': 'D014029', 'term': 'Tobacco Use Disorder'}], 'ancestors': [{'id': 'D015438', 'term': 'Health Behavior'}, {'id': 'D001519', 'term': 'Behavior'}, {'id': 'D019966', 'term': 'Substance-Related Disorders'}, {'id': 'D064419', 'term': 'Chemically-Induced Disorders'}, {'id': 'D001523', 'term': 'Mental Disorders'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D061485', 'term': 'Tobacco Use Cessation Devices'}, {'id': 'D009538', 'term': 'Nicotine'}], 'ancestors': [{'id': 'D013812', 'term': 'Therapeutics'}, {'id': 'D012991', 'term': 'Solanaceous Alkaloids'}, {'id': 'D000470', 'term': 'Alkaloids'}, {'id': 'D006571', 'term': 'Heterocyclic Compounds'}, {'id': 'D011725', 'term': 'Pyridines'}, {'id': 'D006573', 'term': 'Heterocyclic Compounds, 1-Ring'}]}}, 'resultsSection': {'moreInfoModule': {'pointOfContact': {'email': 'szhu@ucsd.edu', 'phone': '858-300-1056', 'title': 'Principal Investigator', 'organization': 'UCSD'}, 'certainAgreement': {'piSponsorEmployee': False, 'restrictiveAgreement': False}}, 'adverseEventsModule': {'eventGroups': [{'id': 'EG000', 'title': 'Usual Care', 'description': 'Subjects are not mailed nicotine patches; however, we facilitate their use by providing a certificate that can be used by the State Medicaid program and some insurance companies to obtain free patches.', 'otherNumAtRisk': 1200, 'otherNumAffected': 0, 'seriousNumAtRisk': 1200, 'seriousNumAffected': 0}, {'id': 'EG001', 'title': 'Patch (Placebo)', 'description': 'Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches. Placebo patches will have no nicotine, but will be packaged to mimic the active patches.', 'otherNumAtRisk': 1201, 'otherNumAffected': 0, 'seriousNumAtRisk': 1201, 'seriousNumAffected': 0}, {'id': 'EG002', 'title': 'Patch (Real)', 'description': 'Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches.', 'otherNumAtRisk': 1799, 'otherNumAffected': 0, 'seriousNumAtRisk': 1799, 'seriousNumAffected': 0}], 'frequencyThreshold': '5'}, 'outcomeMeasuresModule': {'outcomeMeasures': [{'type': 'PRIMARY', 'title': 'Number of Participants With Six-month Continuous Abstinence From Cigarettes', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1200', 'groupId': 'OG000'}, {'value': '1201', 'groupId': 'OG001'}, {'value': '1799', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Usual Care', 'description': 'Subjects are not mailed nicotine patches; however, we facilitate their use by providing a certificate that can be used by the State Medicaid program and some insurance companies to obtain free patches.'}, {'id': 'OG001', 'title': 'Patch (Placebo)', 'description': 'Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches. Placebo patches will have no nicotine, but will be packaged to mimic the active patches.'}, {'id': 'OG002', 'title': 'Patch (Real)', 'description': 'Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches.'}], 'classes': [{'categories': [{'measurements': [{'value': '70', 'groupId': 'OG000'}, {'value': '101', 'groupId': 'OG001'}, {'value': '190', 'groupId': 'OG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': '7 months post enrollment', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED'}, {'type': 'SECONDARY', 'title': 'Number of Participants Quit for 30-days at 2-months Post Enrollment', 'denoms': [{'units': 'Participants', 'counts': [{'value': '1200', 'groupId': 'OG000'}, {'value': '1201', 'groupId': 'OG001'}, {'value': '1799', 'groupId': 'OG002'}]}], 'groups': [{'id': 'OG000', 'title': 'Usual Care', 'description': 'Subjects are not mailed nicotine patches; however, we facilitate their use by providing a certificate that can be used by the State Medicaid program and some insurance companies to obtain free patches.'}, {'id': 'OG001', 'title': 'Patch (Placebo)', 'description': 'Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches. Placebo patches will have no nicotine, but will be packaged to mimic the active patches.'}, {'id': 'OG002', 'title': 'Patch (Real)', 'description': 'Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches.'}], 'classes': [{'categories': [{'measurements': [{'value': '136', 'groupId': 'OG000'}, {'value': '173', 'groupId': 'OG001'}, {'value': '334', 'groupId': 'OG002'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'timeFrame': '2-months post enrollment', 'unitOfMeasure': 'Participants', 'reportingStatus': 'POSTED'}]}, 'participantFlowModule': {'groups': [{'id': 'FG000', 'title': 'Usual Care', 'description': 'Subjects are not mailed nicotine patches; however, we facilitate their use by providing a certificate that can be used by the State Medicaid program and some insurance companies to obtain free patches.'}, {'id': 'FG001', 'title': 'Patch (Placebo)', 'description': 'Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches. Placebo patches will have no nicotine, but will be packaged to mimic the active patches.'}, {'id': 'FG002', 'title': 'Patch (Real)', 'description': 'Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches.'}], 'periods': [{'title': 'Overall Study', 'milestones': [{'type': 'STARTED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '1200'}, {'groupId': 'FG001', 'numSubjects': '1201'}, {'groupId': 'FG002', 'numSubjects': '1799'}]}, {'type': 'COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '1200'}, {'groupId': 'FG001', 'numSubjects': '1201'}, {'groupId': 'FG002', 'numSubjects': '1799'}]}, {'type': 'NOT COMPLETED', 'achievements': [{'groupId': 'FG000', 'numSubjects': '0'}, {'groupId': 'FG001', 'numSubjects': '0'}, {'groupId': 'FG002', 'numSubjects': '0'}]}]}]}, 'baselineCharacteristicsModule': {'denoms': [{'units': 'Participants', 'counts': [{'value': '1200', 'groupId': 'BG000'}, {'value': '1201', 'groupId': 'BG001'}, {'value': '1799', 'groupId': 'BG002'}, {'value': '4200', 'groupId': 'BG003'}]}], 'groups': [{'id': 'BG000', 'title': 'Usual Care', 'description': 'Subjects are not mailed nicotine patches; however, we facilitate their use by providing a certificate that can be used by the State Medicaid program and some insurance companies to obtain free patches.'}, {'id': 'BG001', 'title': 'Patch (Placebo)', 'description': 'Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches. Placebo patches will have no nicotine, but will be packaged to mimic the active patches.'}, {'id': 'BG002', 'title': 'Patch (Real)', 'description': 'Subjects are mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches.'}, {'id': 'BG003', 'title': 'Total', 'description': 'Total of all reporting groups'}], 'measures': [{'title': 'Age, Customized', 'classes': [{'title': '18-24', 'categories': [{'measurements': [{'value': '136', 'groupId': 'BG000'}, {'value': '145', 'groupId': 'BG001'}, {'value': '205', 'groupId': 'BG002'}, {'value': '486', 'groupId': 'BG003'}]}]}, {'title': '25-44', 'categories': [{'measurements': [{'value': '569', 'groupId': 'BG000'}, {'value': '534', 'groupId': 'BG001'}, {'value': '877', 'groupId': 'BG002'}, {'value': '1980', 'groupId': 'BG003'}]}]}, {'title': '45-64', 'categories': [{'measurements': [{'value': '453', 'groupId': 'BG000'}, {'value': '461', 'groupId': 'BG001'}, {'value': '648', 'groupId': 'BG002'}, {'value': '1562', 'groupId': 'BG003'}]}]}, {'title': '65+', 'categories': [{'measurements': [{'value': '40', 'groupId': 'BG000'}, {'value': '61', 'groupId': 'BG001'}, {'value': '68', 'groupId': 'BG002'}, {'value': '169', 'groupId': 'BG003'}]}]}, {'title': 'Unknown', 'categories': [{'measurements': [{'value': '2', 'groupId': 'BG000'}, {'value': '0', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Sex: Female, Male', 'classes': [{'categories': [{'title': 'Female', 'measurements': [{'value': '658', 'groupId': 'BG000'}, {'value': '645', 'groupId': 'BG001'}, {'value': '998', 'groupId': 'BG002'}, {'value': '2301', 'groupId': 'BG003'}]}, {'title': 'Male', 'measurements': [{'value': '542', 'groupId': 'BG000'}, {'value': '556', 'groupId': 'BG001'}, {'value': '801', 'groupId': 'BG002'}, {'value': '1899', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Race/Ethnicity, Customized', 'classes': [{'title': 'White', 'categories': [{'measurements': [{'value': '638', 'groupId': 'BG000'}, {'value': '609', 'groupId': 'BG001'}, {'value': '888', 'groupId': 'BG002'}, {'value': '2135', 'groupId': 'BG003'}]}]}, {'title': 'Black', 'categories': [{'measurements': [{'value': '191', 'groupId': 'BG000'}, {'value': '194', 'groupId': 'BG001'}, {'value': '307', 'groupId': 'BG002'}, {'value': '692', 'groupId': 'BG003'}]}]}, {'title': 'Hispanic', 'categories': [{'measurements': [{'value': '250', 'groupId': 'BG000'}, {'value': '270', 'groupId': 'BG001'}, {'value': '421', 'groupId': 'BG002'}, {'value': '941', 'groupId': 'BG003'}]}]}, {'title': 'Asian', 'categories': [{'measurements': [{'value': '24', 'groupId': 'BG000'}, {'value': '36', 'groupId': 'BG001'}, {'value': '46', 'groupId': 'BG002'}, {'value': '106', 'groupId': 'BG003'}]}]}, {'title': 'American Indian', 'categories': [{'measurements': [{'value': '18', 'groupId': 'BG000'}, {'value': '16', 'groupId': 'BG001'}, {'value': '24', 'groupId': 'BG002'}, {'value': '58', 'groupId': 'BG003'}]}]}, {'title': 'Multi-Race', 'categories': [{'measurements': [{'value': '76', 'groupId': 'BG000'}, {'value': '73', 'groupId': 'BG001'}, {'value': '103', 'groupId': 'BG002'}, {'value': '252', 'groupId': 'BG003'}]}]}, {'title': 'Unknown', 'categories': [{'measurements': [{'value': '3', 'groupId': 'BG000'}, {'value': '3', 'groupId': 'BG001'}, {'value': '10', 'groupId': 'BG002'}, {'value': '16', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Education', 'classes': [{'title': '<12', 'categories': [{'measurements': [{'value': '314', 'groupId': 'BG000'}, {'value': '288', 'groupId': 'BG001'}, {'value': '444', 'groupId': 'BG002'}, {'value': '1046', 'groupId': 'BG003'}]}]}, {'title': 'HS Diploma', 'categories': [{'measurements': [{'value': '405', 'groupId': 'BG000'}, {'value': '378', 'groupId': 'BG001'}, {'value': '595', 'groupId': 'BG002'}, {'value': '1378', 'groupId': 'BG003'}]}]}, {'title': 'Some College', 'categories': [{'measurements': [{'value': '396', 'groupId': 'BG000'}, {'value': '442', 'groupId': 'BG001'}, {'value': '631', 'groupId': 'BG002'}, {'value': '1469', 'groupId': 'BG003'}]}]}, {'title': 'BA/BS or Higher', 'categories': [{'measurements': [{'value': '84', 'groupId': 'BG000'}, {'value': '92', 'groupId': 'BG001'}, {'value': '128', 'groupId': 'BG002'}, {'value': '304', 'groupId': 'BG003'}]}]}, {'title': 'Unknown', 'categories': [{'measurements': [{'value': '1', 'groupId': 'BG000'}, {'value': '1', 'groupId': 'BG001'}, {'value': '1', 'groupId': 'BG002'}, {'value': '3', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Language', 'classes': [{'title': 'English', 'categories': [{'measurements': [{'value': '1068', 'groupId': 'BG000'}, {'value': '1049', 'groupId': 'BG001'}, {'value': '1559', 'groupId': 'BG002'}, {'value': '3676', 'groupId': 'BG003'}]}]}, {'title': 'Spanish', 'categories': [{'measurements': [{'value': '132', 'groupId': 'BG000'}, {'value': '152', 'groupId': 'BG001'}, {'value': '240', 'groupId': 'BG002'}, {'value': '524', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}, {'title': 'Smoke Level', 'classes': [{'title': '6-10', 'categories': [{'measurements': [{'value': '352', 'groupId': 'BG000'}, {'value': '353', 'groupId': 'BG001'}, {'value': '527', 'groupId': 'BG002'}, {'value': '1232', 'groupId': 'BG003'}]}]}, {'title': '11+', 'categories': [{'measurements': [{'value': '848', 'groupId': 'BG000'}, {'value': '848', 'groupId': 'BG001'}, {'value': '1272', 'groupId': 'BG002'}, {'value': '2968', 'groupId': 'BG003'}]}]}], 'paramType': 'COUNT_OF_PARTICIPANTS', 'unitOfMeasure': 'Participants'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'FACTORIAL'}, 'enrollmentInfo': {'type': 'ACTUAL', 'count': 4200}}, 'statusModule': {'overallStatus': 'COMPLETED', 'startDateStruct': {'date': '2009-02'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2020-02', 'completionDateStruct': {'date': '2011-12', 'type': 'ACTUAL'}, 'lastUpdateSubmitDate': '2020-02-11', 'studyFirstSubmitDate': '2009-02-24', 'resultsFirstSubmitDate': '2019-09-06', 'studyFirstSubmitQcDate': '2009-02-24', 'lastUpdatePostDateStruct': {'date': '2020-02-13', 'type': 'ACTUAL'}, 'resultsFirstSubmitQcDate': '2020-02-04', 'studyFirstPostDateStruct': {'date': '2009-02-25', 'type': 'ESTIMATED'}, 'resultsFirstPostDateStruct': {'date': '2020-02-10', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2010-10', 'type': 'ACTUAL'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Number of Participants With Six-month Continuous Abstinence From Cigarettes', 'timeFrame': '7 months post enrollment'}], 'secondaryOutcomes': [{'measure': 'Number of Participants Quit for 30-days at 2-months Post Enrollment', 'timeFrame': '2-months post enrollment'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Nicotine Replacement Therapy', 'Nicotine Patch', 'Smoking cessation', 'Telephone', 'Tobacco cessation', 'Counseling', 'Nicotine', 'Self-Help', 'Smoking abstinence', 'Tobacco Use Disorder'], 'conditions': ['Smoking Cessation']}, 'descriptionModule': {'briefSummary': 'The primary purpose of this study is to determine the effects of distributing free nicotine replacement therapy (NRT) to tobacco quitline callers directly. Specifically, this study aims to:\n\n1. Test if sending active nicotine patches directly will lead to a higher quit rate, compared to a condition where the quitline assists the smokers to obtain patches by other means (e.g. via their health plans).\n2. Test if sending placebo patches directly will also lead to a higher quit rate.\n3. Test if quitline counseling increases the quit rate when the smokers already receive the nicotine patches.', 'detailedDescription': 'Studies have shown that statewide tobacco quitlines can dramatically increase call volume by offering direct mailings of free nicotine replacement therapy (NRT) products. Sending free NRT such as patches to quitline callers, however, often requires a large budget because quitlines have a large number of smokers calling for help each year. A strong rationale is needed for state funding agencies to pay for the patches, which are generally considered the responsibility of health plans. This study will contrast the condition of sending nicotine patches directly from the quitline with a condition where the quitline assists smokers to obtain patches by other means, primarily through their health plans. The study aims to demonstrate that sending patches immediately after smokers call the quitline has a motivational effect that will lead to a higher quit rate than if smokers have to obtain the patches themselves, even if they are able to obtain them for free. To tease apart how much of the effect of sending patches directly from the quitline is due to the active ingredient in the patches and how much is due to motivational effects, this study adds a placebo condition. We hypothesize that the active patches condition will outperform the placebo condition, and the sending of placebo patches will outperform the condition in which the smokers obtain the nicotine patches themselves. We also hypothesize that counseling has its own effect on quitting above and beyond that of the nicotine patches. This study will supply data that can be used to decide what role nicotine replacement therapy should play in publicly funded tobacco cessation programs. Results will also add to the theoretical understanding of behavior change from which new, effective interventions can spring.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* \\>= 18 years old\n* Daily smoker\n* \\>=6 cigarettes per day\n* Ready to quit within one month\n* First time quitline caller\n* Valid phone number\n* Valid address (no P.O. boxes)\n* California resident\n* Agree to participate in study and evaluation\n* English or Spanish speaking\n\nExclusion Criteria:\n\n* Uses other form of tobacco\n* Use of Zyban or Chantix\n* One of the following conditions: Severe allergy to adhesive tape, Arrhythmia, Angina, Heart attack within last year, Stroke within last year, Uncontrolled high blood pressure, Insulin-dependent diabetes, Pregnancy'}, 'identificationModule': {'nctId': 'NCT00851357', 'briefTitle': 'Telephone Counseling and the Distribution of Nicotine Patches to Smokers', 'organization': {'class': 'OTHER', 'fullName': 'University of California, San Diego'}, 'officialTitle': 'The Efficacy of Telephone Counseling and the Centralized Distribution of Nicotine Replacement Therapy Through a Smoking Cessation Quitline', 'orgStudyIdInfo': {'id': 'CDPH 05-45834'}}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Active patches and telephone counseling', 'description': 'Proactive Telephone Counseling and 8-weeks of nicotine patches', 'interventionNames': ['Drug: Nicotine Patch', 'Behavioral: Telephone Counseling']}, {'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo patches and telephone counseling', 'description': 'Proactive Telephone Counseling and 8-weeks of placebo patches', 'interventionNames': ['Behavioral: Telephone Counseling', 'Drug: Placebo']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Telephone counseling', 'description': 'Proactive Telephone Counseling', 'interventionNames': ['Behavioral: Telephone Counseling']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Active patches and materials', 'description': '8-weeks of nicotine patches and materials', 'interventionNames': ['Drug: Nicotine Patch', 'Other: Self-Help Materials']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Placebo patches and materials', 'description': '8-weeks placebo patches and materials', 'interventionNames': ['Drug: Placebo', 'Other: Self-Help Materials']}, {'type': 'ACTIVE_COMPARATOR', 'label': 'Materials', 'description': 'Self-help materials', 'interventionNames': ['Other: Self-Help Materials']}], 'interventions': [{'name': 'Nicotine Patch', 'type': 'DRUG', 'otherNames': ['Habitrol'], 'description': 'Subjects are randomized into 1 of 3 conditions: active, placebo or usual care. Usual care subjects are not mailed patches; however, we facilitate their use by providing a certificate that can be used by the State Medicaid program and some insurance companies to obtain free patches. For those mailed patches directly, we will mail 8 weeks of patches. Dosage depends on the number of cigarettes per day (cpd). Light smokers (6-10 cpd) will receive 6 weeks of 14 mg and 2 weeks of 7 mg patches. Heavy smokers (11+ cpd) will receive 4 weeks of 21 mg, 2 weeks of 14 mg and 2 weeks of 7 mg patches. Placebo patches will have no nicotine, but will be packaged to mimic the active patches.', 'armGroupLabels': ['Active patches and materials', 'Active patches and telephone counseling']}, {'name': 'Telephone Counseling', 'type': 'BEHAVIORAL', 'description': 'Subjects call the Helpline and are screened for services. Eligible clients who give consent will be randomly assigned to a group.\n\nSubjects will be randomized into one of 2 behavioral conditions: telephone counseling or self-help materials. Telephone counseling includes a comprehensive pre-quit session (to include motivation, planning, and setting of a quit date and discussion of nicotine patch use) plus up to 5 proactive follow-up calls. Telephone counseling has several distinguishing features, namely proactive follow up counseling calls, a manualized protocol, and relapse-sensitive scheduling.', 'armGroupLabels': ['Active patches and telephone counseling', 'Placebo patches and telephone counseling', 'Telephone counseling']}, {'name': 'Placebo', 'type': 'DRUG', 'otherNames': ['Non-nicotine patch'], 'description': 'Placebo nicotine patch', 'armGroupLabels': ['Placebo patches and materials', 'Placebo patches and telephone counseling']}, {'name': 'Self-Help Materials', 'type': 'OTHER', 'description': 'Subjects call the Helpline and are screened for services. Eligible clients who give consent will be randomly assigned to a group.\n\nSubjects will be randomized into one of 2 behavioral conditions: telephone counseling or self-help materials. Reading materials and written consent will be mailed to all study subjects the next business day.', 'armGroupLabels': ['Active patches and materials', 'Materials', 'Placebo patches and materials']}]}, 'contactsLocationsModule': {'locations': [{'zip': '92111', 'city': 'San Diego', 'state': 'California', 'country': 'United States', 'facility': "University of Californian, San Diego: California Smokers' Helpline", 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}], 'overallOfficials': [{'name': 'Shu-Hong Zhu, Ph.D.', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'University of California, San Diego'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'University of California, San Diego', 'class': 'OTHER'}, 'collaborators': [{'name': 'California Department of Health Services', 'class': 'OTHER'}], 'responsibleParty': {'type': 'PRINCIPAL_INVESTIGATOR', 'investigatorTitle': 'Professor', 'investigatorFullName': 'Shu-Hong Zhu', 'investigatorAffiliation': 'University of California, San Diego'}}}}